In animal models, GLSO and spore powder effectively reduced tumor weight, volume, and VEGF levels in mice implanted with breast cancer cells (MDA-MB-231) and HCC cells (H22) at doses of 50–200 mg/kg [42,43,44,45]. This evidence concerns the gene VEGFA and breast carcinoma.